Related Subjects:
|Anti-NMDA (NMDAR) receptor encephalitis
|Herpes Simplex Encephalitis (HSV)
|Acute Encephalitis
|Limbic Encephalitis
|Paraneoplastic Limbic Encephalitis (Dementia)
|Steroid-responsive encephalopathy associated with autoimmune thyroiditis (Hashimoto's Encephalopathy)
|Acute Disseminated Encephalomyelitis
|Hashimoto's thyroiditis
|Dementias
π§ Hashimoto's (Steroid-Responsive) Encephalopathy is a rare but completely treatable relapsing neuroendocrine disorder.
It is not directly related to thyroid hormone levels (hypothyroidism or hyperthyroidism).
High titres of anti-thyroid antibodies are usually found.
π Introduction
- Alternate Name: Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT).
π Epidemiology
- β³ Age of Onset: Most often between 45β50 years.
- βοΈ Gender: Over 80% of cases occur in women.
β οΈ Aetiology
- π¬ Nature: Rare autoimmune encephalitis/encephalopathy.
- π¦ Association: Linked with autoimmune thyroiditis (e.g., Hashimotoβs thyroiditis).
- π§ͺ Autoantibodies: Anti-thyroid peroxidase (anti-TPO) and sometimes anti-alpha-enolase.
π©Ί Clinical Features
- π§© Cognitive: Confusion, memory loss, dementia-like picture, psychosis.
- πΆ Motor: Ataxia, myoclonic jerks, seizures.
- π¦ Endocrine: Often with goitre, though thyroid function may be normal or only mildly abnormal.
- π΄ Consciousness: Drowsiness β coma in severe cases.
π Differential Diagnosis
- 𧬠CJD-like illness: Rapid cognitive decline, but CSF 14-3-3 negative in Hashimotoβs.
- π₯ Limbic Encephalitis: Paraneoplastic or autoimmune inflammation of the limbic system.
π¬ Investigations
- π§ͺ Thyroid Function Tests: Normal, hypo- or subclinical hypothyroid.
- π Autoantibodies: High anti-TPO titres Β± other autoimmune antibodies.
- π§ MRI/CT: Often normal or nonspecific (sometimes temporal lobe atrophy, worse left-sided).
- π§ CSF: Raised protein, usually normal cells. 14-3-3 protein negative.
- π EEG: Diffuse slow-wave activity, consistent with cortical dysfunction.
- π§ͺ Other: Viral screens negative, angiography negative.
π Management
- π Steroids: High-dose IV methylprednisolone or oral prednisone β usually dramatic response.
- π Steroid taper + Maintenance: Azathioprine or similar agents may be used long term.
- π Alternative Therapy: Plasma exchange, IVIg, or cyclophosphamide for relapses/non-responders.
- β‘ Seizure Management: Anticonvulsants as required.
π Prognosis
- π Generally good if treated early.
- β³ Improvement may take weeks to months.
- π Relapses possible β long-term monitoring needed.
π References
- ChiΓ², A., & Palladino, R. (2014). Hashimoto's encephalopathy: A review. Frontiers in Neurology, 5, 103.
- Urey, H., & Schiller, H. (2017). SREAT: Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clinical Neurology and Neurosurgery, 157, 71-78.
- Buskila, D., Maimon, N., & Sela, E. (2015). Hashimoto's encephalopathy: A retrospective study. Neurology, 85(16), 1477-1483.
- Marino, S., & McDermott, M. (2016). Hashimoto's encephalopathy: An update. JNNP, 87(10), 1115-1121.